DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Morris C, Wakeling A.
Fulvestrant (‘Faslodex’) – a new treatment option for patients progressing on prior endocrine therapy.
Endocr Relat Cancer 2002;
9: 267-276
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.